1. Scrip
  2. >>COVID-19

Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug

Healios Joins Search For Acute Respiratory Distress Syndrome Treatment

 
• By Scrip Team

As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind Gates Foundation's drug-hunting initiative.

Face_Mask_Stay_Home
A surgical mask showing a map of New York State: the US has overtaken China as the country with most COVID-19 cases, more than half of these in New York

A consortium of life sciences companies including leading pharma firms has announced a collaboration to speed up the development, manufacture and delivery of vaccines, diagnostics and treatments for COVID-19, working with the Bill & Melinda Gates Foundation.

Fifteen companies, including Boehringer Ingelheim International GmbH, bioMerieux SA, Eisai Inc., Eli Lilly & Co., Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc. (MSD), Merck KGaA, Novartis AG, Pfizer Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.

Executives On The Move: Pathos Procures CEO From AstraZeneca, New CEO For TME Pharma, And More

Recent moves in the industry include changes at the top at Akamis Bio, Innospera Pharma & Ispen, plus Astellas Korea appoints an ex-Novartis Korea executive.